GARCIA MARINO (CEO AND PRESIDENT) sold 122.92K shares of DIANTHUS THERAPEUTICS, INC. /DE/ on the open market
Open‑market sale worth $10.02M. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+122.92K
Price / share
$6.70
Trade value
$823.55K
% of position
Common Stock
Shares
−43.51K
Price / share
$80.69
Trade value
$3.51M
% of position
Common Stock
Shares
−65.52K
Price / share
$81.74
Trade value
$5.36M
% of position
Common Stock
Shares
−12.80K
Price / share
$82.60
Trade value
$1.06M
% of position
Common Stock
Shares
−200.00
Price / share
$83.38
Trade value
$16.68K
% of position
Common Stock
Shares
−900.00
Price / share
$85.53
Trade value
$76.98K
% of position
Net shares
+0.00
Net value
-$9.19M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/12/2026 | M · Option Exercise | +122.92K | $6.70 | $823.55K | New position | 0.00 | 122.92K |
| Common Stock Direct | 3/12/2026 | S · Sale | −43.51K | $80.69 | $3.51M | 35.4% | 122.92K | 79.41K |
| Common Stock Direct | 3/12/2026 | S · Sale | −65.52K | $81.74 | $5.36M | 82.5% | 79.41K | 13.90K |
| Common Stock Direct | 3/12/2026 | S · Sale | −12.80K | $82.60 | $1.06M | 92.1% | 13.90K | 1.10K |
| Common Stock Direct | 3/12/2026 | S · Sale | −200.00 | $83.38 | $16.68K | 18.2% | 1.10K | 900.00 |
| Common Stock Direct | 3/12/2026 | S · Sale | −900.00 | $85.53 | $76.98K | New position | 900.00 | 0.00 |
| Total | +0.00 | -$9.19M | ||||||
Stock Option (Right to Buy)
Common Stock
122.92K shares
Shares
−122.92K
Strike price
6.70
Held after
59.74K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock122.92K shares | 3/12/2026 | M · Option Exercise | −122.92K | 6.70 | — | 59.74K |